Halcion side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Halcion. Common side effects include alanine aminotransferase increased among females and anaemia among males.
The phase IV clinical study is created by eHealthMe based on 7,846 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
7,846 people who take Halcion and have side effects are studied.
What is Halcion?
Halcion has active ingredients of triazolam. It is often used in insomnia. eHealthMe is studying from 7,993 Halcion users for its effectiveness, alternative drugs and more.
Number of Halcion reports submitted per year:
Halcion side effects by time on the drug *:
Halcion side effects by gender *:
Halcion side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Halcion?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on triazolam (the active ingredients of Halcion) and Halcion (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Halcion:
- Halcion (7,993 reports)
Common Halcion side effects:
- Fever: 487 reports
- Insomnia (sleeplessness): 332 reports
- Drug ineffective: 269 reports
- Dizziness: 268 reports
All Halcion side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Kevzara and Novolin 70/30 drug interaction - 3 seconds ago
- Pregabalin and Nightmares - 5 seconds ago
- Calcipotriene and Flonase Allergy Relief drug interaction - 6 seconds ago
- Exforge and Weight Loss - 8 seconds ago
- Esbriet and Dermatitis Exfoliative Aggravated - 13 seconds ago
- Peg-Intron and Bacteria Urine Identified - 21 seconds ago
- Primaxin and Peritonitis Bacterial - 37 seconds ago
- Hyperthyroidism and Abdominal Pain - 42 seconds ago
- Belsomra and Hyperventilation - 42 seconds ago
- Alphagan and Ms Contin drug interaction - 50 seconds ago